Close this search box.

British Cannabis Announces New Partnership With Kanabo

Kanabo Group plc (LSE: KNB), the patient-focused provider of digital health services and specialist medicines, including medicinal cannabis, is pleased to announce that it has entered into a partnership with BRITISH CANNABIS™ to supply the CBD by BRITISH CANNABIS™ range of pharmacy-grade CBD health supplements to patients via a prescription service through the Group’s online pain management clinic, Treat It.   

The partnership will allow doctors to prescribe the CBD by BRITISH CANNABIS™ products to patients via the Treat It platform. Focused on secondary care, Treat It enables patients access to healthcare professionals via its secure, digital healthcare platform.

These medical professionals deliver a full diagnosis as part of a personalised patient care plan and are able to offer treatments, including the prescription of medicinal cannabis, for individuals seeking relief from chronic pain. By incorporating CBD by BRITISH CANNABIS™ products into our offerings, Kanabo continues to increase the accessibility and affordability of high quality, alternative pain management solutions to improve overall patient quality of life.

From November, Treat It will also be included in Canndr, an online medicinal cannabis app from BRITISH CANNABIS™ which enables patients to select and review quality cannabis medicines on the market, gain consultancy advice and select from a number of suitable prescribing clinics. 

Avihu Tamir, Chief Executive Officer of Kanabo, commented: 

At Kanabo, we aim to increase medicinal cannabis access for more patients. This partnership allows Treat It doctors to include a wider range of quality CBD supplements in our telemedicine offerings. We’re eager to further enhance patient-centric healthcare and treatment options. This partnership is just the beginning, and we hope to announce more expansive collaborations in due course.”

Steve Batchelor, BRITISH CANNABIS™ Marketing Director commented:

We are thrilled to join forces with Treat It to make CBD products from our long-standing pharmacy retail brand accessible to pain patients through prescriptions. This partnership represents a significant step forward in expanding patient choices and empowering doctors to explore naturally-derived supplements, as alternatives to traditional pharmaceutical care paths.

“We are also pleased that thousands of long-term CBD customers will have the option to consult with Treat It’s network of specialist pain doctors, assessing their own particular needs and determining things like what delivery formats, when and how much CBD they could be taking.”

Related Posts

Related Posts


Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you


Browse by Tags




© 2023 Prohibition Holdings Ltd. All Rights Reserved.


Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?